Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro
- PMID: 8642334
- PMCID: PMC2192558
- DOI: 10.1084/jem.183.5.2247
Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro
Abstract
The influence of costimulation on the primary response of CD8+ T cells to class I alloantigens was studied with the aid of a T cell receptor transgenic model and defined peptides as antigen. With small doses of antigen, the proliferative response of CD8+ cells was high early in culture but was of brief duration and declined to low levels by day 4; this abbreviated response was associated with limited production of interleukin 2 (IL-2) and was strongly dependent upon costimulation via CD8-major histocompatibility complex class I and CD28-B7 interactions. The response to large doses of antigen was quite different in two respects. First, large doses of antigen inhibited the early (day 3) proliferative response but caused a marked elevation of the response late in culture (day 5); these altered kinetics were associated with increased production of IL-2. Second, the initial proliferative response to large doses of antigen did not require costimulation: indeed, blocking costimulation with CTLA4lg or anti-CD8 monoclonal antibody enhanced the early proliferative response. However, blocking costimulation impaired IL-2 production and prevented the late proliferative response. These findings indicate that the requirement for costimulation of T cells can be partly overcome by increasing the dose of antigen to a high level. However, costimulation plays a key role in prolonging the response, presumably by triggering strong and sustained production of IL-2.
Similar articles
-
Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.J Immunol. 2000 Mar 15;164(6):3434-44. doi: 10.4049/jimmunol.164.6.3434. J Immunol. 2000. PMID: 10706740
-
T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.Scand J Immunol. 1996 Jul;44(1):21-9. doi: 10.1046/j.1365-3083.1996.d01-82.x. Scand J Immunol. 1996. PMID: 8693288
-
Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.Exp Hematol. 2003 Jan;31(1):31-8. doi: 10.1016/s0301-472x(02)01018-4. Exp Hematol. 2003. PMID: 12543104
-
The Yin and Yang of T cell costimulation.Science. 1995 Nov 10;270(5238):932-3. doi: 10.1126/science.270.5238.932. Science. 1995. PMID: 7481795 Review. No abstract available.
-
Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.Cell. 1992 Dec 24;71(7):1065-8. doi: 10.1016/s0092-8674(05)80055-8. Cell. 1992. PMID: 1335362 Review. No abstract available.
Cited by
-
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.
-
Administration of a glypican-3 peptide increases the infiltration and cytotoxicity of CD8+ T cells against testicular yolk sac tumor, associated with enhancing the intratumoral cGAS/STING signaling.Cancer Med. 2023 Dec;12(23):21293-21307. doi: 10.1002/cam4.6605. Epub 2023 Nov 20. Cancer Med. 2023. PMID: 37986544 Free PMC article.
-
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.J Clin Invest. 2000 Jun;105(11):1623-30. doi: 10.1172/JCI9177. J Clin Invest. 2000. PMID: 10841521 Free PMC article.
-
Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.J Immunol. 2009 Mar 1;182(5):2909-18. doi: 10.4049/jimmunol.0803545. J Immunol. 2009. PMID: 19234186 Free PMC article.
-
Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.Alcohol Clin Exp Res. 2011 Jan;35(1):47-59. doi: 10.1111/j.1530-0277.2010.01321.x. Epub 2010 Oct 6. Alcohol Clin Exp Res. 2011. PMID: 21039629 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials